Compound Planning, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1978879 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$5,131,046

-$321,804 QoQ

Shares Held

40,613

+3.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#576

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Compound Planning, Inc. holds $102,536,389 across 14 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	124,737	$31,388,818
2	JNJ	Johnson & Johnson	65,795	$16,709,955
3	LLY	ELI LILLY & Co	10,900	$13,073,787
4	MRK	Merck & Co., Inc.	101,296	$13,016,535
5	PFE	Pfizer Inc	242,706	$5,844,359
6	GILD	Gilead Sciences, Inc. This page	40,613	$5,131,046
7	NVS	Novartis AG	30,759	$4,820,549
8	AMGN	Amgen Inc	8,559	$3,099,384

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,131,046	40,613	+3.8%	Shares	Other	2026-08-04
2026-03-31	$5,452,850	39,125	+8.2%	Shares	Sole	2026-05-14
2025-12-31	$4,436,805	36,148	-7.3%	Shares	Defined	2026-02-19
2025-09-30	$4,328,445	38,995	+7.7%	Shares	Sole	2025-11-10
2025-06-30	$4,013,050	36,196	+56.1%	Shares	Sole	2025-08-14
2025-03-31	$2,598,775	23,193	+179.0%	Shares	Sole	2025-05-14
2024-12-31	$767,779	8,312	+36.7%	Shares	Sole	2025-01-17
2024-09-30	$509,831	6,081	+36.0%	Shares	Sole	2024-10-08
2024-06-30	$306,755	4,471	-15.3%	Shares	Sole	2024-07-26
2024-03-31	$386,760	5,280	-8.6%	Shares	Sole	2024-05-07
2023-12-31	$468,075	5,778	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.